Patients with Major Depressive Disorder are the first to benefit from PKB and Clerkenwell’s New Partnership

Clerkenwell Health has contracted with Patients Know Best (PKB) to streamline and accelerate their clinical trial recruitment process, beginning with a dedicated initiative for individuals living with Major Depressive Disorder (MDD). Clerkenwell Health is a UK-based clinical research organisation (CRO) and site network focused on advancing clinical trials in neurological and psychiatric conditions. Since 2021, Clerkenwell Health has worked with more than 20 biotech companies developing treatments for conditions including depression, PTSD, anxiety, addiction, pain, and cognitive disorders.